Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)
Palomino Laboratories (PALX) reported Total Liabilities of $336458.0 for Q4 2025, up 115.08% on a YoY basis from $156431.0 in Q4 2024, and down 66.32% sequentially from $999013.0 in Q3 2025.
Palomino Laboratories (PALX) Total Liabilities (2022 - 2025) Analysis & Trends
Palomino Laboratories (PALX) has 4 years of Total Liabilities data on file, last reported at $336458.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 115.08% year-over-year to $336458.0; the trailing twelve-month figure through Dec 2025 stood at $336458.0 (up 115.08% YoY), and the FY2025 full-year result was $336458.0, up 115.08% from the prior year.
- Total Liabilities declined to $336458.0 in Q4 2025, from $999013.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $27804.0 in Q4 2022.
- A 4-year average of $271921.0 and a median of $194658.0 in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities soared 40.14% in 2024 and jumped 350.51% in 2025, its largest moves.
- Tracing PALX's Total Liabilities over 4 years: stood at $27804.0 in 2022, then jumped by 301.46% to $111621.0 in 2023, then surged by 40.14% to $156431.0 in 2024, then soared by 115.08% to $336458.0 in 2025.
- Business Quant data shows PALX's Total Liabilities at $336458.0 in Q4 2025, $999013.0 in Q3 2025, and $364431.0 in Q2 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,458.00 |
| Sep 30, 2025 | 999,013.00 |
| Jun 30, 2025 | 364,431.00 |
| Mar 31, 2025 | 336,989.00 |
| Dec 31, 2024 | 156,431.00 |
| Sep 30, 2024 | 221,754.00 |
| Jun 30, 2024 | 194,658.00 |
| Mar 31, 2024 | 162,925.00 |
| Dec 31, 2023 | 111,621.00 |
| Sep 30, 2023 | 79,047.00 |
| Dec 31, 2022 | 27,804.00 |